EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie (Phase I)Open Access · CC BY-NC 4.0

The pharmacokinetics of brensocatib in participants with renal impairment following a single oral administration

Sam Au Yeung, Daniel S Stein, Thomas C Marbury, Helen Usansky

British Journal of Clinical Pharmacology · 2025

DOI: 10.1111/bcp.16344 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Sam Au Yeung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Insmed Incorporated, Bridgewater, NJ, United States. Hauptthemen laut MEDLINE: Renal Insufficiency, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Insmed.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Brensocatib is an oral, selective, competitive and reversible dipeptidyl peptidase 1 inhibitor in development for the treatment of bronchiectasis. This study evaluated the pharmacokinetics (PKs), safety and tolerability of brensocatib in participants with varying degrees of renal impairment and normal renal function.

Methods

In this phase 1, multicentre, open‐label study, 28 participants with mild, moderate or severe renal impairment (estimated glomerular filtration rate [eGFR] 60 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal InsufficiencyDipeptidyl-Peptidase IV InhibitorsHumansMaleFemaleMiddle AgedAdministration, OralAgedGlomerular Filtration RateAdultHalf-LifeSeverity of Illness Index

Stichwörter der Autor:innen

clinical pharmacologypharmacokineticsphase 1respiratory medicine

Substanzen

Dipeptidyl-Peptidase IV Inhibitors

Autor:innen und Institutionen

  • Insmed Incorporated, Bridgewater, NJ, United States.
  • Orlando Clinical Research Center, Orlando, FL, United States.

Förderung

  • Insmed

Zitieren

APA

Yeung, S. A., Stein, D. S., Marbury, T. C., & Usansky, H. (2025). The pharmacokinetics of brensocatib in participants with renal impairment following a single oral administration. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16344

Vancouver

Yeung SA, Stein DS, Marbury TC, Usansky H. The pharmacokinetics of brensocatib in participants with renal impairment following a single oral administration. British Journal of Clinical Pharmacology. 2025. doi:10.1111/bcp.16344

BibTeX
@article{Yeung2025,
  author = {Yeung, Sam Au and Stein, Daniel S and Marbury, Thomas C and Usansky, Helen},
  title = {The pharmacokinetics of brensocatib in participants with renal impairment following a single oral administration},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1111/bcp.16344}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche